We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Chemiluminescent Substrate Increases Sensitivity of Western Blot Assays

By LabMedica International staff writers
Posted on 11 May 2010
An extremely sensitive substrate kit for use in procedures to detect proteins by the Western blotting method has now been released to the market.

The PerkinElmer (Waltham, MA, USA) Western Lightning Ultra chemiluminescent substrate kit is a very sensitive system for detection of horseradish peroxidase (HRP) on membranes, with maximum sensitivity in the low femtogram (10-15 g) range. More...
It incorporates a novel enhancer that intensifies a signal generated by peroxidase-catalyzed oxidation of luminol. The substrate produces a signal at 425 nm for at least eight hours, making it ideal for use with a wide variety of CCD (charge-coupled device) imagers as well as Kodak BioMax Light or X-OMAT Blue film. Membranes may be stripped and re-probed for detection of multiple targets.

PerkinElmer maintains that the Western Lighting Ultra reagent produces outstanding sensitivity, a wide dynamic range, and stable signal for assured results in all areas of life sciences research. Additionally, the kit helps reduce the use of primary antibodies by tenfold, providing more information from smaller samples, for faster and more economical research outcomes.

"Life sciences researchers increasingly recognize a growing need for producing data through highly sensitive methods of detecting proteins of interest, under a variety of challenging experimental conditions,” said Dr. Martina Bielefeld-Sévigny, vice president for bio-discovery at PerkinElmer. "We have addressed these needs with the new Western Lighting Ultra detection kit. Researchers can now take advantage of a more stable signal and dynamic range that provides more accurate results. Ultimately, this capability will benefit investigations of potential new drugs, providing deeper insights into their effectiveness against critical diseases.”

Related Links:

PerkinElmer



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Rapid Test Reader
DIA5000
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.